Effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation.
	    		
		   		
		   			
		   		
	    	
    	- VernacularTitle:HBsAg-树突状细胞疫苗对肝移植后免疫抑制状态大鼠抗-HBs产生的影响
 - Author:
	        		
		        		
		        		
			        		Yue LI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xian-Feng CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Zuo-Jin LIU
			        		
			        		;
		        		
		        		
		        		
			        		Jian-Ping GONG
			        		
			        		;
		        		
		        		
		        		
			        		Sheng-Wei LI
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Adjuvants, Immunologic; pharmacology; Animals; Cytokines; blood; genetics; metabolism; Dendritic Cells; immunology; Disease Models, Animal; Hepatitis B; immunology; prevention & control; Hepatitis B Antibodies; blood; immunology; Hepatitis B Surface Antigens; immunology; Hepatitis B Vaccines; Immunosuppression; Immunosuppressive Agents; administration & dosage; Liver Transplantation; immunology; Male; RNA, Messenger; genetics; metabolism; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Secondary Prevention; Spleen; immunology; metabolism
 - From: Chinese Journal of Hepatology 2010;18(1):32-36
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo explore the effects of HBsAg pulsed dendritic vaccination on anti-HBs production in immunosuppressed rats after liver transplantation (LT).
METHODSBrown-Norway liver allografts were transplanted into Lewis recipients. The transplanted Lewis rats were injected with EK506 (2 mg/kg) and randomly divided into two groups: rats in HBsAg-DCs group (n = 15) were intraperitoneally injected with HBsAg pulsed DCs at 14 d and 28 d after LT, and rats in the HBsAg group (n = 15) were injected with HBsAg (200 mul) once a week for 12 weeks. Rats without any immunosuppressive treatment after LT served as controls (n = 5). IL-2 and IFN-gamma mRNA expression in spleen were analyzed by RT-PCR, serum IL-2, IFN-gamma and anti-HBs were detected by ELISA.
RESULTSHigh dose of FK506 resulted in the immunosuppressed in LT rats, as evident by low production of IL-2 and IFN-gamma, and without liver rejection compared to rats in the control group. HBsAg-DCs induced high titer of anti-HBs antibody, however, titer of anti-HBs were seldom detectable in the HBsAg group at 1, 2 and 3 mouth after vaccination.
CONCLUSIONThe capacity of HBsAg-DCs to induce anti-HBs in immunosuppressed rats suggested that DC vaccine may prevent HBV recurrence in liver transplanted patients.
 
            